137 related articles for article (PubMed ID: 10383283)
1. Gastropathy due to celecoxib, a cyclooxygenase-2 inhibitor.
Mohammed S; Croom DW
N Engl J Med; 1999 Jun; 340(25):2005-6. PubMed ID: 10383283
[No Abstract] [Full Text] [Related]
2. COX-2 inhibitors and Celebrex: safe or suspect?
Health News; 1999 Jun; 5(7):4. PubMed ID: 10932776
[No Abstract] [Full Text] [Related]
3. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].
Bannwarth B
Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B79-84. PubMed ID: 11449148
[No Abstract] [Full Text] [Related]
4. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
Atkinson HG
Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
[No Abstract] [Full Text] [Related]
5. [Hyperkalemia and celecoxib].
Rego MJ; Fonseré N; Martí S; Rey-Joly C
Med Clin (Barc); 2002 Jun; 119(1):36-7. PubMed ID: 12062005
[No Abstract] [Full Text] [Related]
6. [Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?].
Hinz B; Brune K
MMW Fortschr Med; 2000 Mar; 142(11):39-40. PubMed ID: 10786088
[No Abstract] [Full Text] [Related]
7. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
Chan FK; Hung LC; Suen BY; Wu JC; Lee KC; Leung VK; Hui AJ; To KF; Leung WK; Wong VW; Chung SC; Sung JJ
N Engl J Med; 2002 Dec; 347(26):2104-10. PubMed ID: 12501222
[TBL] [Abstract][Full Text] [Related]
8. [Selective cyclooxygenase-2 inhibitors and the digestive tract].
Chaabouni H; Amouri A; Cheikh I; Kchaou M; Ouerghi H; Ben Mami N; Ben Ammar A
Tunis Med; 2002 Aug; 80(8):427-33. PubMed ID: 12703120
[TBL] [Abstract][Full Text] [Related]
9. Allergic vasculitis associated with celecoxib.
Jordan KM; Edwards CJ; Arden NK
Rheumatology (Oxford); 2002 Dec; 41(12):1453-5. PubMed ID: 12468830
[No Abstract] [Full Text] [Related]
10. Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group.
Dahlén B; Szczeklik A; Murray JJ;
N Engl J Med; 2001 Jan; 344(2):142. PubMed ID: 11188419
[No Abstract] [Full Text] [Related]
11. Balancing the risks and benefits of celecoxib.
Caldwell B; Beasley R; Weatherall M; Metcalfe S
Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734
[No Abstract] [Full Text] [Related]
12. Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
Lanas A
N Engl J Med; 2003 Jun; 348(24):2464-6; author reply 2464-6. PubMed ID: 12802035
[No Abstract] [Full Text] [Related]
13. [Role of prostaglandins in the pathogenesis of stomach ulcer and gastropathy caused by non-steroid anti-inflammatory drugs].
Lazebnik LB; Tkachenko VN; Kolomiets EV
Eksp Klin Gastroenterol; 2005; (1):4-7, 106. PubMed ID: 15991845
[TBL] [Abstract][Full Text] [Related]
14. Erectile dysfunction induced probably by celecoxib.
Dhikav V; Gupta S; Anand KS
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):211-2. PubMed ID: 18236511
[No Abstract] [Full Text] [Related]
15. Celecoxib-induced upper gastrointestinal hemorrhage and ulceration.
Crawford AS; White JG
South Med J; 2002 Dec; 95(12):1444-6. PubMed ID: 12597315
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
Goldstein JL; Cryer B; Amer F; Hunt B
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
[TBL] [Abstract][Full Text] [Related]
17. [Adverse effects of NSAID are insidious. No pain--despite life threatening gastric hemorrhage].
MMW Fortschr Med; 2002 Sep; 144(37):55. PubMed ID: 12380342
[No Abstract] [Full Text] [Related]
18. Does celecoxib use increase the risk of cardiovascular events?
Oviedo JA; Schroy PC
Gastroenterology; 2005 Oct; 129(4):1348-50. PubMed ID: 16230088
[No Abstract] [Full Text] [Related]
19. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS
Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?
Chen JT; Pucino F; Resman-Targoff BH
J Pain Palliat Care Pharmacother; 2006; 20(4):11-32. PubMed ID: 17182503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
